These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 5004576
21. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens]. Muratov VV, Pashkov IuN, Pospelov VV. Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646 [No Abstract] [Full Text] [Related]
22. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol]. Serra C, Andreis G. G Ital Chemioter; 1966 Dec; 13(1):109-27. PubMed ID: 4967318 [No Abstract] [Full Text] [Related]
24. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol]. Oury M, Tuchais E, Norval C, Carbonnelle B, Leroux MF, Corre C, Parvery F. Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321 [No Abstract] [Full Text] [Related]
28. [Neutralization of the sputum in newly detected patients with pulmonary tuberculosis treated during the years 1967 to 1970]. Panajotović H, Marsenić B. Plucne Bolesti Tuberk; 1974 Jun; 26 Suppl 2():105-9. PubMed ID: 4216916 [No Abstract] [Full Text] [Related]
30. Drug resistance to the first line of antitubercular regimen (a preliminary report). Varaiya A, Gogate A. Indian J Public Health; 1998 Jun; 42(4):126-30. PubMed ID: 10389525 [Abstract] [Full Text] [Related]
32. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis]. Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, Terekhova ND. Probl Tuberk Bolezn Legk; 2005 Jun; (12):37-9. PubMed ID: 16496762 [Abstract] [Full Text] [Related]
33. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents]. Kamińska M, Czajka-Kropaczek L, Ciechanowska A. Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657 [No Abstract] [Full Text] [Related]
35. [Progress and prospects in chemotherapy of pulmonary tuberculosis]. Anastasatu C. Med Interna (Bucur); 1972 Sep; 24(9):1039-48. PubMed ID: 4651382 [No Abstract] [Full Text] [Related]
37. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM, Bakare NA, Onadeko BO. Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [Abstract] [Full Text] [Related]
38. Appropriateness of extending the intensive phase of treatment based on smear results. Enarson DA, Jindani A, Kuaban C, Lamothe F, Louissaint M, Ottmani SE, Ramarokoto H, Ridderhof JC, Urbanczik R. Int J Tuberc Lung Dis; 2004 Jan; 8(1):114-6. PubMed ID: 14974754 [No Abstract] [Full Text] [Related]
39. Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of 2 years chemotherapy. Aquinas M, Citron KM. Tubercle; 1972 Sep; 53(3):153-65. PubMed ID: 4116993 [No Abstract] [Full Text] [Related]
40. [Rifampycine in the treatment of chronic pulmonary tuberculosis]. Pacheco CR, Cordero O, Sierra D, Pacheco Mde J, Vázquez E. Gac Med Mex; 1974 Jun; 107(6):505-11. PubMed ID: 4448354 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]